Let's follow a simple logic here. Countries are beginning to ease COVID-19 restrictions and promising more aggressive testing to prevent the infection making a comeback. The only way this will work is if there are quick and effective test kits like the one AT1 has, that are easy to use and can return results quickly. If tests take too long or have to be administered by medical staff, this will create a huge strain on the health infrastructure and will not work in the long run. There will be a pressure to make the testing process efficient and effective and there is already a huge demand for it all over the globe. It will come down to manufacturing and distribution capability, which shouldn't be too difficult to solve.
The self-administered test kits that are easy and quick to use by either medical staff or individuals is the future of testing, not just for COVID-19 but for any other viral disease outbreaks. So the potential is huge as unfortunately there will be no shortage of threatening viral diseases any time soon. AT1 has a working, patented device, and all the institutions and high net worth individuals buying into AT1 know exactly what they're buying into.
AT1 Price at posting:
48.0¢ Sentiment: Buy Disclosure: Held
